Fasting at Night May Aid Glucose Metabolism in Night-Shift Workers
By Lori Solomon HealthDay Reporter
THURSDAY, Nov. 14, 2024 -- Fasting at night prevents impairments in glucose tolerance among simulated night-shift work, according to a study published online Oct. 18 in Diabetologia.
Stephanie Centofanti, Ph.D., from University of South Australia in Adelaide, and colleagues assigned healthy, non-shift-working adults without obesity to fasting-at-night (20 individuals), snack-at-night (17 individuals), or meal-at-night (18 individuals) conditions.
The researchers found that night-shift work significantly impaired insulin sensitivity, as measured by insulin area under the curve (AUC) and the insulin sensitivity index across all conditions. Measures of insulinogenic index were significantly heightened in the fasting-at-night condition only, resulting in a day-by-condition interaction in glucose AUC, with glucose tolerance impaired in the meal-at-night and snack-at-night conditions compared with the fasting-at-night condition. There was also a day-by-condition interaction for nonesterified fatty acid AUC, which was higher in the meal-at-night and snack-at-night conditions compared with the fasting-at-night condition.
"The timing of food intake has a critical effect on glucose metabolism during simulated night-shift work, which was readily amendable to a meal retiming intervention," the authors write. "Meal timing advice should be considered for existing dietary guidelines, industry recommendations, and workplace policy to improve health and reduce the burden of metabolic disease on night-shift workers."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-15 06:00
Read more
- Music Might Speed Your Recovery From Surgery
- Travel Time to Tanning Facilities Negatively Linked to Melanoma Incidence
- Can Cannabis Change Your Brain? Maybe, Maybe Not
- Progression-Free Survival Improved With Nivolumab + AVD in Hodgkin Lymphoma
- FDA Accepts New Drug Application and Grants Priority Review for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent
- Demographics, Smell Test, and Cognitive Test Can Predict Cognitive Decline, Dementia
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions